Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Flovent Diskus (Fluticasone Propionate) Inhalation Powder
Company:  GlaxoWellcome Inc.
Application No.:  020833
Approval Date: 9/29/2000


Date created: December 062004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.